GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oscotec 039200.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

36,150

-0.41%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩99.84bn

FY2016FY2025

Net income

₩52.34bn

FY2016FY2025

Free cash flow

₩7.52bn

FY2016FY2025

Shareholders' equity

₩181.31bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩99.84bn₩34.01bn₩4.95bn₩5.06bn₩3.90bn₩43.47bn₩4.37bn₩18.70bn₩3.91bn₩3.55bn
Gross profit₩97.89bn₩31.78bn₩2.92bn₩3.04bn₩1.95bn₩41.58bn₩2.27bn₩16.27bn₩2.22bn₩2.06bn
Research and development₩27.64bn₩21.43bn₩24.91bn₩23.34bn₩22.71bn₩32.79bn₩15.41bn₩6.97bn₩4.82bn₩6.55bn
Operating income₩52.08bn−₩3.41bn−₩32.66bn−₩29.30bn−₩29.11bn₩1.36bn−₩21.93bn₩6.18bn−₩3.66bn−₩4.11bn
Net income₩52.34bn₩876.5m−₩24.28bn−₩24.43bn−₩26.26bn−₩4.36bn−₩22.44bn₩3.47bn−₩3.89bn−₩3.65bn
Diluted earnings per share1,368.1522.92-639.20-664.88-829.41-140.60-797.88127.34-70.82-137.27

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩229.85bn₩170.78bn₩132.58bn₩143.74bn₩48.97bn₩76.39bn₩72.39bn₩70.26bn₩40.54bn₩40.81bn
Cash and short-term investments——₩97.48bn₩103.70bn₩14.58bn₩28.13bn₩52.72bn₩35.66bn₩23.38bn₩9.78bn
Total liabilities₩43.01bn₩38.42bn₩37.86bn₩21.23bn₩20.14bn₩23.34bn₩21.11bn₩23.97bn₩19.30bn₩14.49bn
Debt——₩6.35bn₩10.08bn₩7.25bn₩1.72bn₩6.71bn₩11.24bn₩13.24bn₩10.65bn
Shareholders' equity₩181.31bn₩127.76bn₩98.92bn₩122.51bn₩28.83bn₩53.05bn₩51.29bn₩46.29bn₩21.24bn₩26.33bn
Shares outstanding38m38m38m37m32m31m28m27m55m27m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩8.30bn−₩26.03bn−₩22.05bn−₩26.42bn−₩8.76bn−₩17.88bn₩27.5m−₩5.08bn−₩3.69bn−₩8.21bn
Capital spending−₩779.6m−₩691.9m−₩581.2m−₩1.25bn−₩7.52bn−₩5.22bn−₩4.19bn−₩1.72bn−₩61.5m−₩7.08bn
Free cash flow₩7.52bn−₩26.73bn−₩22.63bn−₩27.67bn−₩16.28bn−₩23.10bn−₩4.16bn−₩6.80bn−₩3.75bn−₩15.28bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩52.65bn₩3.65bn₩78.94bn₩8.95bn₩10.02bn₩1.94bn₩2.34bn₩29.06bn
Gross profit₩52.21bn₩3.14bn₩78.38bn₩8.39bn₩9.55bn₩1.58bn₩2.22bn₩28.39bn
Operating income₩52.21bn−₩9.99bn₩61.41bn−₩373.2m−₩631.9m−₩8.32bn−₩7.04bn₩19.64bn
Net income₩36.66bn−₩2.73bn₩60.62bn−₩489.3m−₩1.85bn−₩5.94bn−₩4.86bn₩16.90bn
Diluted earnings per share958.14-71.231,584.50-12.79-48.28-155.33-127.12441.99
Cash from operations₩49.80bn₩48.00bn₩726.0m−₩7.92bn−₩9.94bn₩25.41bn−₩26.03bn−₩17.97bn
Capital spending−₩407.0m−₩453.0m−₩66.0m−₩25.0m−₩588.0m−₩99.0m−₩691.0m−₩440.0m
Free cash flow₩49.39bn₩47.55bn₩660.0m−₩7.95bn−₩10.53bn₩25.31bn−₩26.72bn−₩18.41bn
Total assets₩267.18bn₩222.34bn₩229.85bn₩154.14bn₩158.03bn₩163.29bn₩170.78bn₩171.22bn
Cash and short-term investments——————₩102.72bn₩109.50bn
Debt——————₩6.07bn₩6.08bn
Shareholders' equity₩215.92bn₩178.91bn₩181.31bn₩119.38bn₩119.77bn₩121.79bn₩127.76bn₩132.04bn

Financial ratios

Data as of 27 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin98.1%93.5%59.0%60.0%50.0%95.6%———
Operating margin52.2%-10.0%-659.6%-578.7%-745.9%3.1%———
Net margin52.4%2.6%-490.4%-482.6%-672.9%-10.0%———
Return on equity28.9%0.7%-24.5%-19.9%-91.1%-8.2%———
Return on assets22.8%0.5%-18.3%-17.0%-53.6%-5.7%———
Free cash flow yield——————0.4%-0.4%-0.2%
Revenue growth193.6%586.9%-2.2%29.7%-91.0%895.1%———
Earnings growth5871.6%-103.6%-0.6%-7.0%502.8%-80.6%———
Current ratio5.10x4.06x2.94x5.81x1.18x3.54x———
Debt to equity——0.06x0.08x0.23x0.02x0.05x0.08x—
Equity ratio78.9%74.8%74.6%85.2%58.9%69.4%———
Interest coverage22.96x-3.14x-80.31x-92.59x-270.43x1.92x———
R&D as a share of sales27.7%63.0%503.1%461.1%581.9%75.4%———
Buybacks as a share of market value——————-3.2%50.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue170.2%18.1%18.5%
Operating income—107.3%51.3%
Net income——63.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin96.9%94.3%93.7%87.7%
Operating margin36.4%-9.2%-21.5%-26.5%
Net margin39.8%3.1%-13.7%-21.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings33.0—-36.1-26.0-42.2-445.8-28.9169.6-221.9-49.8
Price to sales17.327.4176.8125.6283.744.7148.231.5221.151.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Dec 2008.

FY2009FY2008FY2007
Paid in the year11.94423.88823.888
  • 832-for-795 split · 27 Sept 2022
  • 2-for-1 split · 29 Dec 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.